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The pool of primordial follicles determines the reproductive lifespan of the mammalian female, and its
establishment is highly dependent upon proper oocyte cyst breakdown and regulation of germ cell
numbers. The mechanisms controlling these processes remain a mystery. We hypothesized that KIT
signaling might play a role in perinatal oocyte cyst breakdown, determination of oocyte numbers and the
assembly of primordial follicles. We began by examining the expression of both KIT and KIT ligand in fetal
and neonatal ovaries. KIT was expressed only in oocytes during cyst breakdown, but KIT ligand was
present in both oocytes and somatic cells as primordial follicles formed. To test whether KIT signaling
plays a role in cyst breakdown and primordial follicle formation, we used ovary organ culture to inhibit
and activate KIT signaling during the time when these processes occur in the ovary. We found that when
KIT was inhibited, there was a reduction in cyst breakdown and an increase in oocyte numbers.
Subsequent studies using TUNEL analysis showed that when KIT was inhibited, cell death was reduced.
Conversely, when KIT was activated, cyst breakdown was promoted and oocyte numbers decreased.
Using Western blotting, we found increased levels of phosphorylated MAP Kinase when KIT ligand was
added to culture. Taken together, these results demonstrate a role for KIT signaling in perinatal oocyte
cyst breakdown that may be mediated by MAP Kinase downstream of KIT.
& 2013 Elsevier Inc. All rights reserved.Introduction
Female fecundity is determined at the time of birth through the
establishment of the primordial follicle pool and any aberration
in the formation of primordial follicles can result in infertility.
Follicular formation is tightly regulated and begins during fetal life
in the mouse. After migration to the gonad, primordial germ cells
(PGCs) divide rapidly but do not complete cytokinesis and are
connected by intercellular bridges, forming germ cell cysts
(Pepling and Spradling, 1998; Peters, 1970). As the germ cells
enter meiosis, they cease mitotic division and remain connected
until they begin to arrest in the diplotene stage of meiosis I. At that
time, the germ cells, now called oocytes, begin to separate from
each other and become surrounded by somatic granulosa cells,
forming primordial follicles. The process of cyst breakdown and
primordial follicle formation typically lasts from 17.5 days post
coitum (dpc) to post natal day (PND) 5 (Borum, 1961; Menke et al.,
2003). Concomitant with cyst breakdown is a large loss of oocytes,
beginning at approximately 17.5 dpc and peaking betweenll rights reserved.
racuse University, 114 Life
244, USA.
burg College, Lynchburg, VA,PND 2 and 3 of development (Pepling and Spradling, 2001).
The mechanisms regulating both perinatal cyst breakdown and
oocyte survival remain a mystery. One pathway of interest may be
the KIT signaling pathway, as it has been previously shown to be
important in germ cell survival and follicle progression at several
stages of development.
KIT signaling is widely known for its ability to promote cell
survival, proliferation and differentiation. The receptor, KIT, and its
ligand, KIT ligand (KITL) also known as Stem cell factor (SCF), are
encoded by the White spotting and Steel loci, respectively. Muta-
tions at either locus have been studied extensively and result in an
array of developmental defects in melanogenesis, hematopoiesis
and gametogenesis (Roskoski, 2005). Signaling depends on the
binding of KITL to KIT and when bound, KIT homodimerizes and
autophosphorylates at tyrosine residues, attracting and binding
downstream signaling molecules containing phosphotyrosine
binding sites. KIT autophosphorylation is capable of activating
several downstream cascades, including the Janus Kinase (JAK)-
Signal Transducer and Activator of Transcription (STAT), Phospha-
tidylinositol 3-kinase (PI3K), and Mitogen-activated Protein Kinase
(MAPK) pathways (Schlessinger, 2000).
KITL exists in both a soluble isoform and a membrane bound
isoform (Roskoski, 2005). The soluble form (KITL1) is a result of
cleavage of the transmembrane portion of the protein, allowing
the protein to dislodge from the cell membrane. The membrane
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the transmembrane cleavage site, forcing the protein to remain
anchored at the cell membrane (Ashman, 1999). The exact function
of each isoform is not well understood, however it has been
reported that KITL2 binding results in more sustained KIT signaling
(Miyazawa et al., 1995).
The KIT pathway has been shown to be important for many
ovarian functions including germ cell survival and migration. Early
studies examining Steel mutant mice demonstrated the impor-
tance of this signaling pathway in the proper migration of PGCs to
the genital ridge. A decrease in KITL expression results in PGC
migration to ectopic sites and a reduction in germ cell proliferation
and survival (Huang et al., 1993; Huang et al., 1992; McCoshen and
McCallion, 1975). Reynaud and colleagues demonstrated that KITL
and KIT were also imperative to later follicular survival, protecting
pre-antral follicles from apoptosis (Reynaud et al., 2001). Finally,
ovaries of newborn rats exposed to recombinant KITL in culture
had a lower percentage of dying oocytes than control ovaries
(Jin et al., 2005).
Postnatal development of follicles is also dependent on the KIT
ligand/KIT system. After birth, the ﬂattened granulosa cells of
primordial follicles become cuboidal and proliferate, forming the
primary follicle. This change from primordial to primary follicle
has been shown to be dependent on the KIT pathway in several
studies. Steelpanda mutant mice, a KITL hypomorph which produces
only a small amount of KITL, show a nearly complete block on the
primordial to primary follicle transition, leaving a large pool of
primordial follicles that cannot develop. These mice are sterile
(Huang et al., 1993). In another experiment, when neonatal mice
were injected with the KIT neutralizing antibody, ACK2, the
transition from primordial to primary follicle was severely blocked
(Yoshida et al., 1997). Conversely, when exogenous KITL was added
to 4 day old rat ovaries in culture, there was a signiﬁcant increase
in developing primordial follicles (Parrott and Skinner, 1999).
These experiments demonstrate the importance of KIT signaling
in primordial follicle development, and studies have begun to
describe an involvement of the KIT signaling pathway in an
oocyte-granulosa cell feedback loop. During the primordial to
primary transition, KIT activation at the oocyte regulates other
molecules downstream that affect granulosa cell division. Otsuka
and Shimasaki found that in the presence of KITL, granulosa cell
mitosis increased, indicating an indirect regulation of granulosa
cell division via the oocyte KIT signal (Otsuka and Shimasaki,
2002). In the same study, when a KIT neutralizing antibody was
added, granulosa cell division decreased.
KIT signaling is also important in a subsequent stage of follicle
development, the transition from preantral to antral follicle. As the
granulosa cells of primary follicles divide to produce multiple
layers, a secondary or preantral follicle is formed. These preantral
follicles eventually gain a ﬂuid ﬁlled space, and are then classiﬁed
as antral follicles. Yoshida and colleagues were able to block the
transition from the preantral to the antral follicle stage by ACK2
antibody injection (Yoshida et al., 1997). Similarly, when ACK2 was
used to block KIT signaling in rat ovary culture, a block on
gonadotropin induced preantral follicle development was seen
(Parrott and Skinner, 1999).
Although much evidence exists for the role of KIT signaling in
ovarian development, the contribution of KIT signaling to primor-
dial follicle formation in later fetal and early neonatal develop-
ment is unclear. In hamster, KIT signaling has been shown to
promote cyst breakdown and primordial follicle formation in vitro
(Wang and Roy, 2004). However, using an injection of a KIT
neutralizing antibody, Yoshida et al., failed to ﬁnd any role for
KIT in primordial follicle formation in newborn mouse ovaries
(Yoshida et al., 1997). Since KIT is directly involved in, and
important to, early survival of oocytes and subsequent postnataldevelopment of follicles, we hypothesized that this pathway might
also regulate the formation of primordial follicles from oocyte
cysts. In the current study we took advantage of an organ culture
system to directly inhibit and activate KIT signaling in fetal ovaries,
when cyst breakdown and follicle formation begin. Our results
illustrate the importance of this pathway in the establishment of
the primordial follicle pool.Materials and methods
Animals
All C57BL/6 mice were purchased from Jackson Laboratories.
Adult male and female mice were mated utilizing timed matings,
and females were checked for the presence of a vaginal plug the
following morning. The presence of a vaginal plug was denoted
0.5 dpc of pregnancy. Pregnant mice were euthanized on either
17.5 dpc for organ culture experiments or 16.5, 17.5 and 18.5 dpc
for immunohistochemistry. Otherwise, pregnant dams gave birth
at 19.5 dpc (PND 1) and pups were euthanized at PND 1 and 3 for
immunohistochemistry.
All mice were housed under 12 h light/dark cycles, tempera-
tures of 21–22 1C and had free access to chow and water. All
animal protocols were approved by the Syracuse University
Institutional Animal Care and Use Committee.
Antibodies
For immunohistochemistry, STAT3 (C-20) antibody (Santa Cruz
Biotechnology) was used at a dilution of 1:500, KIT (C-19) and
Stem Cell Factor (G-19) antibodies (Santa Cruz Biotechnology)
were used at a dilution of 1:100, VASA antibody (Abcam)
was used at a dilution of 1:250. The secondary antibodies, goat
anti-rabbit Alexa 488, rabbit anti-goat Alexa 488 and goat anti-
rabbit Alexa 568 (Invitrogen), were at a dilution of 1:200. A
Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) kit (Intergen) was used to visualize dying oocytes. For
Western blotting, AKT 1/2/3 (H-136), phospho-AKT 1/2/3 (Ser473),
STAT3 (C-20) and phospho-STAT3 (Tyr 705) antibodies (Santa
Cruz Biotechnology) were used at a dilution of 1:1000. MAPK
p44/42 ERK1/2 and Phospho-p44/42 (T202/Y204) antibodies
(Cell Signaling) were used at a dilution of 1:1000 for Western
blotting.
In vitro ovary organ culture
As previously described, ovaries were harvested and placed on
0.4 mm ﬂoating ﬁlters (Millicell-CM; Millipore Corp) in 4 well
culture dishes (Nunc) with 0.4 ml culture media consisting of
D-MEM/HAM’S F12 Media (Invitrogen), 0.1% Albumax (Invitrogen),
0.1% Fraction V BSA (Invitrogen), 5X ITS-X (Life Technologies),
0.05 mg/ml L-ascorbic acid (Sigma) and penicillin–streptomycin
(Life Technologies) (Chen et al., 2007). Each ﬂoating ﬁlter held 2–3
ovaries, and a single drop of media was placed on each of the
ovaries to keep them from drying out.
To assess the role of KIT signaling in the ovary, 17.5 dpc ovaries
were cultured for 5 days in either media alone, media supple-
mented with a function blocking antibody to KIT, ACK2 (e-
biosciences) at a 1:100 dilution, media supplemented with recom-
binant Stem Cell Factor (R&D Systems) at 100 ng/ml or media
supplemented with IgG (Santa Cruz) at a 1:100 dilution (n¼8
ovaries per group). To determine the role of KIT signaling before
PND 1, ovaries (n¼8 ovaries per group) were cultured for 3 days
either in control media alone, or in media supplemented with
ACK2 at 17.5 dpc then switched to control media after 2 days in
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ovaries (n¼8) were grown in culture for 5 days either in control
media alone, or in control media at 17.5 dpc then switched to
media supplemented with ACK2 after 2 days in culture. For cell
death and proliferation studies, ovaries were cultured in control or
ACK2 supplemented media for 3 days (n¼8 ovaries per group).Fig. 1. Expression of KIT in the fetal and neonatal ovary. Confocal sections from 16.5 dpc
for KIT (green) (A, D, G, J and M) and the nuclear marker, propidium iodide (red) (B, E, H,
area within the white circle and arrows indicate oocytes without KIT labeling while a
arrowheads indicate somatic cells. (P–R) KIT labels a subset of oocytes at PND 1. Confo
antibody, (Q) KIT (red) antibody and (R) overlay. In P–R, arrows indicate oocytes withouAt the conclusion of culture, all ovaries were prepared for whole-
mount immunohistochemistry.
To determine pathways regulated by KIT signaling, 17.5 dpc
ovaries were grown in culture for 3 days in either control media or
media supplemented with SCF (n¼8). At the conclusion of culture,
ovaries were prepared for Western blotting.(A–C), 17.5 dpc (D–F), 18.5 dpc (G–I), PND 1 (J–L), and PND 3 (M–O) ovaries labeled
K and N) with overlay shown in C, F, I, L and O. Inset in L is an enlarged image of the
rrowheads denote oocytes with KIT labeling. Arrows in G–I indicate oocytes and
cal section of a PND 1 ovary labeled with (P) the germ cell marker, VASA (green)
t KIT labeling and arrowheads denote oocytes with KIT labeling. Scale bar, 20 mm.
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Ovaries were ﬁxed in 5% EM-grade paraformaldehyde (Electron
Microscopy Sciences) overnight at 4 1C and stained as previously
described (Pepling and Spradling, 1998). Whole ovaries were
labeled with primary antibody overnight, then with anti-rabbit
or anti-goat secondary antibody. Nuclei were labeled with TOTO-3
or propidium iodide (Invitrogen). A Zeiss LSM 710 Confocal
Microscope was used to image ovaries. As a control, some ovaries
were labeled with only anti-rabbit secondary antibody.
Analysis of oocyte cyst breakdown and follicle development
At the conclusion of cultures, ovaries prepared for immunohis-
tochemistry were labeled with STAT3 antibody, a known oocyte
marker and imaged with confocal microscopy (Murphy et al.,Fig. 2. Expression of KITL in the fetal and neonatal ovary. Confocal sections from 16.5 dp
for KITL (green) (A, D, G, J and M) and the nuclear marker, propidium iodide (red) (B, E, H
arrowheads indicate somatic cells. Scale bar, 20 mm.2005). In each ovary, two randomly selected cores were visualized
and counted. A core is a region 135135 mm2 made up of optical
sections at 4 separate depths in the ovary 15–20 mm apart, with
the ﬁrst section beginning in the outer cortex and the last section
ending within the medullar region of the ovary so that ovarian
development is assessed in all regions. For each ovary, 2 cores with
4 optical sections were analyzed for a total of 8 sections examined.
The number of oocytes found in cysts relative to the total number
of oocytes was determined for each ovary by analyzing each
section and reported as percent single oocytes. In order to
determine whether oocytes were in cysts or not, for each of the
4 optical sections in a core, a z-stack of images each 1 mm apart
was obtained with 5 images above the section and 5 images below
the section being analyzed. This allowed us to determine whether
an oocyte was part of a germ cell cyst above or below the plane of
focus. Follicle development was determined by counting thec (A–C), 17.5 dpc (D–F), 18.5 dpc (G–I), PND 1 (J–L), and PND 3 (M–O) ovaries labeled
, K and N) with overlay shown in C, F, I, L and O. Arrows in M–O indicate oocytes and
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relation to the total number of follicles found and reported as
percent primordial, primary or secondary follicles.Analysis of oocyte numbers
To determine oocyte numbers, we counted the number of oocytes
found within the 8 optical sections used for analyzing cyst breakdown
and follicle development. The numbers were averaged and reported
as number of oocytes per section. Only ovaries that appeared to be of
similar size and depth were used for counting oocyte numbers
because the number of oocytes per section is an estimate of the total
number of oocytes within an ovary.Analysis of cell death
To analyze dying cells, ovaries were ﬁrst labeled with the TUNEL
labeling kit (Intergen) according to the manufacturers recommenda-
tions and then with the oocyte marker antibody, VASA. Ovaries were
imaged with confocal microscopy. In each ovary, 4 randomly selected
optical sections were visualized and analyzed by counting the number
of TUNEL positive cells relative to the total number of cells present.
This number was reported as % TUNEL positive cells per ovary.Fig. 3. Expression of KIT and cleaved PARP at PND 1. Confocal sections of a PND 1 ovary la
(E) KIT (red) antibody and (C) and (F) overlay. Arrowheads indicate oocytes with KIT label
for both KIT and cleaved PARP proteins or negative for KIT but positive for cleaved PARWestern blot hybridization
17.5 dpc ovaries were grown in culture for 3 days and then
homogenized in 10 ml sample buffer (2% SDS, 10% Glycerol, 0.005%
Bromophenol Blue, 0.0625 M Tris pH 6.8, and 2.5% 2-mercaptoetha-
nol) plus mini-complete protease inhibitors (Roche) per ovary. Addi-
tional 2-mercaptoethanol was added to extracts at 1/10 of the volume
of extract. Samples were then heated to 95 1C and centrifuged at
6000 rpm for 1 min, separated on a 10% SDS- polyacrylamide gel
(BioRad) and then electroblotted onto either Immobilon P PVDF
(Millipore) or nitrocellulose (BioRad) membranes. Membranes were
blocked in either Phosphate Buffered Saline plus 0.05% Tween (PBST)
containing 5% nonfat milk for AKT, phospho-AKT, MAPK p44/42 and
STAT3 antibodies or Tris Buffered Saline plus 0.05% Tween (TBST)
with 5% BSA for phospho-p44/42 and phospho-STAT3 antibodies for
1 h at room temperature. Blots were then incubated with primary
antibody diluted in the appropriate blocking solution for 1 h at room
temperature. Membranes were washed 3–6 times in either PBST or
TBST then incubated with secondary antibody diluted in 5% milk
blocking solution for 1 h at room temperature. Goat anti-rabbit
horseradish peroxidase conjugated secondary antibody (Thermo-
scientiﬁc) for the AKT, pAKT, MAPK p44/42 and STAT3 hybridized
blots was used at a dilution of 1:10,000 and at a dilution of 1:15,000
for phospho-p44/42 MAPK and phospho-STAT3 hybridized blots.
Again, blots were washed 3–6 times in PBST or TBST and bands werebeled with (A) and (D) the cell death marker, cleaved PARP (green) antibody, (B) and
ing and arrows indicate oocytes without KIT labeling. (G) Percent of oocytes positive
P protein. Data are presented as the mean7SEM.
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reprobed with anti-mouse GAPDH (1:5000; Santa Cruz Biotechnol-
ogy) as a control.
Statistical analysis
A Student's t-test was used to analyze cell death and studies
analyzing the effect of blocking KIT in the ovary at different time
points. Effects of ACK2 and recombinant SCF on ovaries cultured
for ﬁve days beginning on 17.5 dpc were analyzed with a one-way
ANOVA using SPSS statistical software. For all results, p values less
than 0.05 were considered signiﬁcant.Results
Expression of KIT and KITL in the ovary
We ﬁrst examined the expression of both KIT and KITL in the fetal
and neonatal ovary to determine if KIT signaling could be involved in
oocyte survival and follicle formation at the time of birth. To evaluate
expression, we harvested ovaries from 16.5 dpc, 17.5 dpc, 18.5 dpc,
PND 1 and PND 3 mice, ﬁxed and labeled them with an antibody to
either KIT or KITL. Fig. 1 shows the expression of KIT weakly in the
cytoplasm of oocytes at 16.5 (A–C) and 17.5 (D–F) dpc, and expression
at the cell membrane appears in a few oocytes at 17.5 dpc (only oneFig. 4. Ovarian follicle formation is affected by KIT signaling. (A) Timeline showing the 5
(B) Number of oocytes, (C) percent single oocytes and (D) percent of follicles found at the
5 days either in control media alone or media supplemented with IgG at 1:100, ACK2
indicates a signiﬁcant difference between groups (ANOVA, po0.05). (E) Confocal section
for STAT3 (green) to visualize oocytes and propidium iodide (red) to visualize nuclei. Scoocyte with expression at the membrane in the panel shown). At 18.5
dpc (Fig. 1G–I) KIT is expressed in a subset of the oocytes in either the
cytoplasm or cell membrane but becomes pronounced at the cell
membrane of oocytes by PND 1 (Fig. 1J–L). Interestingly, at PND 1 a
small subset of cells within a cyst do not express KIT (inset Fig. 1L). KIT
protein appears to be similarly expressed at PND 3 although it may be
less pronounced at the membrane (Fig. 1M–O). To demonstrate that
KIT labels oocytes, we used immunohistochemistry on PND 1 ovaries
and labeled themwith an antibody to KIT and to the germ cell marker,
VASA. Fig. 1 Q–R shows that KIT labels only oocytes at PND 1 and that
some oocytes within a cyst do not express KIT.
We also tested for the presence of KITL in fetal and neonatal
ovaries. Fig. 2A–C shows weak expression of KITL in the cytoplasm
of germ and somatic cells at 16.5 dpc. By 17.5 dpc, KITL appears to
accumulate in small areas of some oocytes, which may represent
expression of the membrane bound isoform of KITL (Fig. 2D–F).
From 18.5 dpc onward, KITL expression remains in the cytoplasm
of oocytes and somatic cells (Fig. 2G–O) and expression appears to
increase from PND 1 to 3.
Based on previous work showing that KIT signaling was respon-
sible for oocyte survival, we hypothesized that the oocytes within a
cyst not expressing KIT at PND 1 would be marked for apoptosis.
To test this, we double labeled PND 1 ovaries with an antibody to the
apoptosis marker, cleaved PARP, and the germ cell marker, VASA.
Fig. 3A–F shows representative confocal sections demonstrating that
some oocytes expressing KIT and some oocytes not expressing KIT areday culture period (orange bar) and duration of ACK2 or KITL treatment (blue bar).
primordial, primary or secondary stage per confocal section in ovaries cultured for
at 1:100, or 100 ng/mL KITL. Data are presented as the mean7SEM. Asterisk (n)
of an ovary cultured for 5 days in control media or (F) with ACK2 antibody labeled
ale bar, 20 mm.
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percentage of oocytes in each confocal section labeling with both the
KIT and PARP antibodies and those that do not label with KIT but are
positive for PARP (Fig. 3G). There was not a statistically signiﬁcant
difference between these groups. Thus there does not appear to be a
correlation between KIT signaling and oocyte survival.
KIT signaling regulates oocyte numbers, primordial follicle formation
and cyst breakdown
We ﬁrst hypothesized that KIT signaling might regulate peri-
natal germ cell numbers by increasing oocyte survival for those
expressing KIT. To test this, we harvested 17.5 dpc ovaries and
placed them in organ culture for 5 days in either control media
alone, media supplemented with a 1:100 dilution of the KIT
function blocking antibody, ACK2, media supplemented withFig. 5. KIT signaling is important for follicle formation and development from 17.5 dpc t
ACK2 treatment (blue bar). (B) Number of oocytes, (C) percent single oocytes and (D) p
section in ovaries cultured for 5 days either in control media alone (days 1–5) or media s
(days 3–5). (E) Timeline showing the 3 day culture period (orange bar) and timing of
(H) percent of follicles found at the primordial, primary or secondary stage per confoca
media supplemented with ACK2 at 1:100 (days 1 and 2) and subsequently in control med
between groups (t-test, po0.05).100 ng/ml of recombinant KITL or media supplemented with
1:100 dilution of IgG as a negative control (Fig. 4A). Surprisingly,
we found an increase in the number of oocytes present in the
ACK2 inhibited ovaries (14.5 oocytes) and a reduction in the
number of oocytes in KITL treated ovaries (5.8 oocytes) when
compared with both control and IgG treated ovaries (8.7 oocytes
and 8.1 oocytes; Fig. 4B). In addition, we found that when KIT
signaling was blocked with ACK2, a large reduction in cyst break-
down occurred with only 47% single oocytes found, while an
increase in cyst breakdown was present in KITL treated ovaries
which contained 84% single oocytes (Fig. 4C). These were both
statistically different from the control and IgG groups which had
71.1% single oocytes and 77.4% single oocytes, respectively
(Fig. 4C). Finally, both blocking and activating the KIT signaling
pathway resulted in changes in follicle development. The ACK2
inhibited ovaries showed a complete block on follicle progressiono PND 1. (A) Timeline showing the 5 day culture period (orange bar) and timing of
ercent of follicles found at the primordial, primary or secondary stage per confocal
upplemented with ACK2 at 1:100 (days 1 and 2) and subsequently in control media
ACK2 treatment (blue bar). (F) Number of oocytes, (G) percent single oocytes and
l section in ovaries cultured for 3 days either in control media alone (days 1–3) or
ia (day 3). Data are presented as the mean7SEM. n indicates a signiﬁcant difference
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in the primary or secondary stages (Fig. 4D). Follicle development
was facilitated by the addition of KITL to culture and resulted in
78% of follicles found at the primordial stage, 21% at the primary
stage and 1% at the secondary stage (Fig. 4D). Normal follicle
development, as demonstrated by the control ovaries, showed an
average of 87% primordial follicles, 13% primary follicles and 0%
secondary follicles (Fig. 4D). Fig. 4E and F are representative
confocal sections of both control and ACK2 treated ovaries
demonstrating the increase in oocytes and reduction in cyst
breakdown found in KIT inhibited ovaries.
Kit signaling contributes to follicle formation before and after birth
Yoshida and colleagues injected female neonatal mice with
ACK2 every other day beginning on PND1 and found no effect on
oocyte numbers prior to PND 5 (Yoshida et al., 1997). Additionally,
they did not evaluate oocyte cyst breakdown and follicle forma-
tion, although they found normal numbers of primordial follicles
in the ovary at PND 5. We wondered if the discrepancy between
our results and those ﬁndings was a result of the timing of the
ACK2 treatment, as cyst breakdown has been shown to begin prior
to PND 1 (Pepling et al., 2010). Therefore, we wanted to test the
effects of inhibiting KIT signaling on cyst breakdown and oocyte
number speciﬁcally before birth to determine if the signal was
important for follicle formation at that time. We began by
culturing 17.5 dpc ovaries for 5 days either in media alone, or in
media supplemented with ACK2 antibody for the ﬁrst two days of
culture then in media alone for the remaining 3 days of culture to
test the effects of inhibiting KIT signaling only before birth
(Fig. 5A). Fig. 5B and C show no signiﬁcant differences in oocyte
numbers or in cyst breakdown when ovaries were cultured with
ACK2 for only the ﬁrst two days of culture. There was, however, aFig. 6. KIT signaling is important for follicle formation in ovaries from PND 1–4. (A) Tim
(blue bar). (B) Number of oocytes, (C) percent single oocytes and (D) percent of follicles
cultured for 5 days either in control media alone (days 1–5) or control media (days 1 an
are presented as the mean7SEM. n indicates a signiﬁcant difference between groups (tsigniﬁcant decrease in follicle development when KIT signaling
was inhibited only for the ﬁrst two days of culture, with ACK2
treated ovaries containing 96% primordial and 4% primary follicles
compared to 87% primordial and 13% primary in control ovaries
(Fig. 5D). These data suggest that KIT signaling has either no effect
on cyst breakdown or oocyte numbers before birth, or that both
were affected but rescued by removing the KIT antibody from
culture and allowing treated ovaries to grow in plain media for the
remaining 3 days of culture.
To better clarify the effect of blocking KIT signaling before birth,
we decided to place 17.5 dpc ovaries in culture and treat with
ACK2 antibody again for the ﬁrst two days, but this time cultured
them only an additional day in plain media (Fig. 5E). A length of
three days of culture was chosen because the ﬁnal day would
correspond to PND 2, the time when germ cell death peaks and
cyst breakdown is well underway (Pepling and Spradling, 2001).
As shown in Fig. 5F, there was no signiﬁcant difference in the
number of oocytes present in treated ovaries. However, cyst
breakdown was greatly reduced with ACK2 treated ovaries con-
taining only 49% single oocytes while control ovaries had 69%
single oocytes (Fig. 5G). Finally, follicle development was inhibited
when KIT signaling was inhibited. Fig. 5H shows that ACK2 treated
ovaries had 99% primordial and 1% primary follicles and control
ovaries had 94% primordial and 6% primary follicles.
Kit signaling is important for follicle formation after birth
Since cyst breakdown is a continuous process lasting from
approximately 17.5 dpc to PND 5, we wanted to determine
whether KIT signaling was still important for follicle formation
after birth (Pepling et al., 2010). To test this, we cultured 17.5 dpc
ovaries for 5 days in either control media alone, or control media
for the ﬁrst two days of culture and then in ACK2 supplementedeline showing the 5 day culture period (orange bar) and timing of ACK2 treatment
found at the primordial, primary or secondary stage per confocal section in ovaries
d 2) and subsequently in media supplemented with ACK2 at 1:100 (days 3–5). Data
-test, po0.05).
Fig. 7. Inhibition of KIT signaling decreases cell death. 17.5 dpc ovaries were cultured for 3 days either in control media alone or in the presence of ACK2 at 1:100.
(A) Timeline showing the 5 day culture period (orange bar) and timing of ACK2 treatment (blue bar). (B) Percent of cells in 17.5 dpc ovaries cultured for 3 days with ACK2 that
are positive for TUNEL. Data are presented as the mean7SEM. * indicates a signiﬁcant difference between control and treated ovaries (t-test, po0.05). (C) Confocal section of
a control ovary showing apoptotic TUNEL positive cells (green), oocytes labeled for the oocyte speciﬁc protein VASA (red) and nuclei labeled with TOTO-3 (blue). (D) Confocal
section of an ACK2 treated ovary showing apoptotic TUNEL cells (green), oocytes labeled for the oocyte speciﬁc protein VASA (red) and nuclei labeled with TOTO-3 (blue).
Scale bar, 20 mm. Arrows indicate dying cells.
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signiﬁcant difference in the number of oocytes in the ACK2 treated
ovaries (9.8 oocytes) when compared with controls (8.2 oocytes;
Fig. 6B), cyst breakdown was signiﬁcantly reduced with ACK2
treatment (Fig. 6C) with inhibited ovaries having 59.1% single
oocytes and control ovaries containing 77% single oocytes. Finally,
follicle development was reduced with ACK2 treated ovaries
containing signiﬁcantly fewer primary follicles than control ovar-
ies (Fig. 6D).
Cell death is modulated by KIT inhibition
Our results showed that KIT signaling is important for regulat-
ing cyst breakdown and oocyte numbers. Upon KIT inhibition in
the ovary, we found the number of oocytes present in the ACK2
treated group was greater than controls (Fig. 4B). It is possible that
the increase in oocyte number was either due to a decrease in cell
death. To test this, we placed 17.5 dpc ovaries in organ culture for
3 days, ending on the day of peak oocyte death (Pepling and
Spradling, 2001), to assess cell death in the ovary when KIT
signaling was inhibited. Ovaries were either grown in control
media alone, or in the presence of the ACK2 antibody for 3 days
(Fig. 7A). At the conclusion of culture, ovaries were ﬁxed and
assessed for cell death using a TUNEL assay. Ovaries that were
treated with the KIT inhibitor consisted of fewer dying cells and
had only 2.3% TUNEL positive cells compared to 8.0% dying in
controls (Fig. 7B). Fig. 7C and D are representative confocal
sections of a control and ACK2 inhibited ovary showing fewer
TUNEL positive cells in ACK2 treated ovaries.
KITL activates the MAP Kinase pathway
Kit signaling can activate several different pathways down-
stream of the receptor, and we wondered which of these pathways
might be involved in cyst breakdown. To evaluate the downstreamsignaling pathway activated by KIT signaling during cyst break-
down, ovaries were cultured for 3 days in either control media
alone, or in media supplemented with recombinant KITL to
activate KIT signaling (Fig. 8A). At the conclusion of culture, ovaries
were prepared for Western blotting and extracts were probed for
total AKT, MAPK and STAT3 as well as the phosphorylated forms of
these proteins. Fig. 8 B–G shows that both control and KITL treated
ovaries contain similar levels of total AKT, STAT3 and MAPK
proteins. Phosphorylated AKT and STAT3 levels were also compar-
able between control and KITL ovaries. KITL treatment did,
however, increase phosphorylation of MAPK, indicating that KITL
activates the MAPK pathway downstream of KIT.Discussion
Although many studies have shown a role for KIT signaling in
ovarian development, there is sparse evidence examining its
importance in oocyte cyst breakdown and primordial follicle
formation. Several labs have examined mice mutant for either
the Steel or W loci, and have found dramatic defects in PGC
migration and proliferation that result in a complete loss of
oocytes by birth (Huang et al., 1993; Reith et al., 1990). These
mice are not optimal for observing the effects of KIT signaling on
cyst breakdown, as cysts do not appear to form in these mutant
ovaries and there are few oocytes remaining. Other Steel mutants
show a decreased number of germ cells, but normal primordial
follicle formation (Bedell et al., 1995). However, these mice
continue to secrete low amounts of KITL which may allow for
normal cyst breakdown and follicle formation. The present study
examines the role of KIT signaling in cyst breakdown and primor-
dial follicle assembly using an organ culture systemwhich permits
the study of KIT signaling speciﬁcally at the time these processes
are occurring. Using this in vitro system, we have elucidated a role
for KIT signaling in the fetal and neonatal mouse ovary.
Fig. 8. Kit ligand activates the MAPK pathway. (A) Timeline showing the 5 day culture period (orange bar) and duration of KITL treatment (blue bar). (B–G) 17.5 dpc ovaries
were grown in culture with (+) or without () KITL for 3 days and prepared for Western blotting analysis. Ovary extracts were probed for (B) total AKT (56 kDa), (C) total
STAT3 (92 kDa), (D) total MAPK (44 and 42 kDa), (E) phosphorylated AKT (56 kDa), (F) phosphorylated STAT3 (92 kDa), and (G) phosphorylated MAPK (44 and 42 kDa).
All extracts were probed for the loading control GAPDH.
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17.5 dpc to PND 3. This supports the ﬁndings of Manova et al.,
where Kit mRNA was localized to the oocyte beginning in just a
few cells at 17.5 dpc then increasingly throughout the life of the
oocyte (Manova et al., 1990). Interestingly, we found that at PND
1 a subset of oocytes within some cysts did not express the KIT.
This may be due to expression of Activin in those cells. Using
immunohistochemistry, Coutts and colleagues found human fetal
ovaries expressed KIT incongruously in oocyte cysts and those that
lacked expression stained positively for Activin (Coutts et al.,
2008). We examined the expression of Activin in neonatal mouse
ovaries and found that it was expressed in somatic cells and not in
oocytes (data not shown). Thus, the expression pattern of Activin
does not appear to be conserved between mice and humans.
Finally, we found that KITL was expressed in the mouse ovary from
17.5 dpc through PND 3 in both oocytes and somatic cells, however
the signal for KITL was strongest in oocytes at 17.5, but then becomes
more evenly distributed between germ cells and granulosa cells by
PND 3. It is possible that there is a switch from the KITL membrane
bound isoform at 17.5 dpc in the oocyte to the soluble form by PND 1,
and this switch may take part in regulation of cyst breakdown. This
could indicate either an autocrine or paracrine signaling mechanism
for the KIT/KITL system in the developing mouse ovary particularly
during follicle formation as expression of both components was
detected during this time period.
Given the positive expression of both KIT and KITL in the mouse
ovary, we hypothesized that this system would play a role in cyst
breakdown and primordial follicle formation. To test this, we used
in vitro ovary organ culture to both inhibit and activate the KIT
signaling pathway. When exposed to the KIT inhibiting antibody
ACK2, cyst breakdown was greatly reduced, and upon activation
with recombinant KITL, cyst breakdown was accelerated. Our data
supports that of Wang and Roy in hamster ovary, where addition
of KITL to culture promoted the formation of primordial follicles
(Wang and Roy, 2004). Alternatively, our results contradict earlierﬁndings that suggest that KIT signaling has no effect on follicle
formation in mouse ovary (Yoshida et al., 1997). Using injections of
ACK2 every other day beginning on the day of birth, Yoshida and
colleagues failed to ﬁnd that KIT played any role in primordial
follicle formation, but instead blocked the primordial to primary
follicle transition. This study utilized newborn mice at PND 1 and,
based on work from our lab showing that cyst breakdown begins
as early as 17.5 dpc, injecting at PND 1 may have been too late a
time to affect cyst breakdown and follicle formation (Pepling et al.,
2010). Additionally, the every other day injection schedule of ACK2
may have allowed a rescue of cyst breakdown, such that on
the days when antibody was not given, normal signaling was
permitted and primordial follicle formation occurred.
In an effort to clarify the differences in our results and those of
Yoshida et al. 1997, we ﬁrst wanted to test the effect of blocking
KIT prior to PND 1 to determine its importance in inhibiting cyst
breakdown before birth. To accomplish this, we cultured 17.5 dpc
ovaries in the presence of ACK2 for 2 days and then allowed the
ovaries to continue in culture in control media for the remaining
3 days. To our surprise, ovaries that were treated only on the ﬁrst
two days had only a slight decrease in cyst breakdown, but a delay
in follicle development remained, suggesting a possible rescue of
cyst breakdown and follicle formation on the 3 days ovaries were
not in the presence of the antibody. To test the idea that follicle
formation had been rescued, we again cultured 17.5 dpc ovaries in
the presence of ACK2 for 2 days but this time only allowed them
to be cultured for 1 more day before examining them. When
removed from culture at the earlier time point, ovaries that were
treated with ACK2 demonstrated a signiﬁcant decrease in cyst
breakdown and primordial follicle formation. This suggests that
follicle formation can be rescued when ovaries are allowed to
resume normal KIT signaling and in addition, the KIT signal is
important before birth in cyst breakdown.
We also postulated that the KIT signal would continue to be
important for cyst breakdown at birth, as this process continues
R.L. Jones, M.E. Pepling / Developmental Biology 382 (2013) 186–197196from 17.5 dpc to PND 5. To examine this, we cultured 17.5 dpc
ovaries ﬁrst in control media for 2 days and then in ACK2
supplemented media for the remaining 3 days. In support of our
hypothesis, we found that cyst breakdown was again inhibited,
though not as severely as when inhibition was started at 17.5 dpc.
The KIT signal appears to be important for cyst breakdown on or
after PND 1 in the neonatal ovary.
In our initial experiment, inhibiting KIT signaling in culture for
5 days from 17.5 dpc onward also resulted in an increase in the
number of oocytes present in the ovary. We suspected that this
increase might be due to a decrease in cell death. Using a TUNEL
analysis, we were able to quantify the percentage of dying cells in
both control and ACK2 treated ovaries and found that the inhibited
ovaries contained a lower percentage of dying cells. Although we
used VASA antibody to label oocytes, we cannot say for sure that
the dying cells are actually oocytes because the germ cell marker
antibody may lose reactivity in dying cells, therefore dying oocytes
may no longer be positive for VASA (Pepling and Spradling, 2001).
However, since KIT is expressed only at the oocyte membrane and
we see an increase in oocyte numbers, it is likely that the
decreased TUNEL labeling upon KIT inhibition is due to a reduction
in oocyte speciﬁc death.
Much of the work in the ovary has focused on the activation of
the PI3K pathway downstream of KIT in the oocyte. When KIT is
activated by KITL, KIT is autophosphorylated at tyrosine 719 which
is the primary binding site for the p85 subunit of PI3K leading to
its subsequent activation. Mice with a point mutation in KIT at
Y719 are not able to bind p85 and therefore cannot activate PI3K
downstream of KIT (John et al., 2009). These mice undergo normal
cyst breakdown and primordial follicle formation, suggesting the
PI3K pathway is not involved in primordial follicle formation upon
KIT activation (Sun et al., 2008). In our study, we have identiﬁed
that MAPK is activated downstream of KIT when KITL binds the
receptor. We used whole ovary protein extracts for Western blot to
identify the pathways activated by KIT therefore, we cannot
conclude that the upregulation of MAPK by KITL is actually
occurring in the oocyte. Future studies will need to examine in
which cell types MAPK becomes phosphorylated when KITL is
added to culture. Presumably MAPK phosphorylation would be
within the oocyte since the KIT is found at the oocyte membrane.
Also, future experiments should include using recombinant KITL in
conjunction with an inhibitor to MAPK signaling to determine
whether this pathway is truly regulating cyst breakdown as a
result of activated KIT signaling.
In summary, we have found a role for KIT in the formation of
primordial follicles using an in vitro ovary culture system to block
KIT signaling speciﬁcally at the time when cyst breakdown and
primordial follicle formation begin. While the in vitro system is a
reliable method for testing the effects of hormones and signaling
molecules on ovarian development, it may not accurately reﬂect
what is happening in vivo. Developing and evaluating a tissue
speciﬁc knockout of KIT would shed light on the importance of this
pathway during cyst breakdown in vivo. Additionally, studying the
genes regulated downstream of KIT is essential to understanding
its role in primordial follicle formation and further, in its effect on
somatic cell division. Trombly et al., found that blocking Notch
signaling in vitro resulted in a defect in primordial follicle forma-
tion in the mouse ovary (Trombly et al., 2009). Interestingly, the
Notch receptor (NOTCH2) is expressed on the granulosa cells and
its ligand, Jagged 1 (JAG1), is present in oocytes. This may be a
pathway involved in an oocyte granulosa cell feedback system
with the KITL/KIT system, where activation of KIT in the oocyte
might upregulate JAG1 expression in the oocyte, resulting in
communication with NOTCH2 at the granulosa cells. Testing the
expression of both NOTCH2 and JAG1 by quantitative RT-PCR or
Western blot following organ culture with exogenous KITL wouldbe a valuable follow up study. Likewise, culture with recombinant
KITL could be followed by a microarray analysis to determine the
global genes being regulated by KIT signaling in the ovary during
cyst breakdown. Finally, it would be interesting to determine if KIT
signaling might act synergistically or redundantly with other
pathways that have been identiﬁed as regulators of cyst break-
down and primordial follicle formation. Studies examining Con-
nective Tissue Growth Factor (CTGF) and Nerve Growth Factor
(NGF) have demonstrated a role for both of these signaling path-
ways in primordial follicle assembly and cyst breakdown, so
experiments that explore the effects of inhibiting and activating
multiple signaling pathways in conjunction with KIT could prove
worthwhile (Dissen et al., 2001; Schindler et al., 2010).Acknowledgments
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